Skye Bioscience, Inc. Common Stock (SKYE)
$3.38 -$0.01 (-0.30%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$163.52M -
Day's Range
$3.21 - $3.47 -
Volume
187,611 -
52 Week Low / High
$2.25 - $19.41 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
SKYE's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 3
- Strong Buy
- 3
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $18.25
- Target Price
Company News
-
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players — Sep 20th, 2024
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players Earlier on Friday, Novo Nordisk A/S (NYSE:NVO) announced headline results from a phase 2a clinical trial with monlunabant, a small-molecule oral cannabinoid receptor 1 (CB1) inverse agonist. After 16 weeks of treatment, pe...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$